PAA 2.50% 20.5¢ pharmaust limited

Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing, page-27

  1. 525 Posts.
    lightbulb Created with Sketch. 89
    Don't disagree with you NZ.

    Like most of PAA announcements the SP initially goes up. Be interesting to see what it is at close.

    For non-holders who I gather would only brieflly read the ann, seeing 12 mths more of trialling would be a turnoff, particullarly so if they know PAA in the past hasen't got close to stated timelines.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.